PPD has appointed Hacene Makerri as VP of its central laboratory organization Singapore: Global CRO, Pharmaceutical Product Development, (PPD) has appointed Hacene Mekerri as vice president of its central laboratory organization. "Hacene has ... Bio Spectrum Asia, 2 weeks ago
PPD's Appoints Central Lab Head - CPhI.cn, 2 weeks ago
PPD Appoints Central Lab Head - Contract Pharma, 2 weeks ago
MIAMI--(EON: Enhanced Online News Jim is uniquely qualified to establish and execute our commercial plans for RAYALDEE in the US. His deep knowledge of the chronic kidney disease market will help bring RAYALDEE to Stage 3 and 4 CKD patients Mr.EON: Enhanced Online News, 4 days ago Opko Health Announces Appointment Of As Senior Vice President Of Pharmaceutical Sales BioSpace, 4 days ago OPKO HEALTH : Announces Appointment of James DeMarco as Senior Vice President of Pharmaceutical Sales 4 Traders, 4 days ago
Pharmaceutical Product Development (PPD) has announced that Hacene Mekerri has joined the global CRO to serve as vice president of its central laboratory organization. Hacene has a unique combination of data management and systems expertise, as ...Center Watch, 1 week ago PPD Names VP to Head Central Laboratory American Pharmaceutical Outsourcing, 2 weeks ago Industry Leader Named to Head PPD's Central Laboratory PredictWallStreet, 2 weeks ago Industry Leader Named To Head PPD???s Central Laboratory BioSpace, 2 weeks ago
Prometheus Diagnostic Test Validated in Anticipation of U.S. Healthcare Provider Demand for Celltrion's INFLECTRA Biosimilar Infliximab
By a News Reporter-Staff News Editor at Pharma Business Week Prometheus Laboratories Inc. announced that the PROMETHEUS Anser IFX test has been validated for use in patients treated with INFLECTRA (biosimilar infliximab) in the management of ...Pharmacy Choice, 4 days ago Prometheus Laboratories Inc. Diagnostic Test Validated In Anticipation Of U.S. Healthcare Provider Demand For Celltrion's INFLECTRA (Biosimilar Infliximab) BioSpace, 3 weeks ago TAKEDA PHARMACEUTICAL : Launches Multi-Year Research Partnership with Leading Inflammatory Bowel Disease Institutions 4 Traders, 3 weeks ago
Euromonitor International Konimex Pharmaceutical Laboratories PT in Health and Wellness (Indonesia) Konimex Pharmaceutical Laboratories PT (Konimex) is expected to further strengthen its presence in HW packaged food in the forecast period, in ...MarketResearch.com, 1 week ago
10:08 IST Anurag is a seasoned chemical, pharmaceutical and life sciences industry professional, having acquired a wealth of business and product management experience during his 17 years of strategic, operational and financial leadership. ...India Infoline, 21 hours ago DSM Sinochem Appoints Anurag Roy As Business Unit Director Businessworld India, 1 day ago
Laboratory of America Holdings (NYSE: LH ) Q1 2016 Earnings Conference Call April 25, 2016 09:00 AM ET Executives Paul Surdez - VP, IR Dave King - Chairman & CEO Glenn Eisenberg - EVP and CFO Deborah Keller - CEO, Covance Drug ...Seeking Alpha, 4 days ago Abbott Laboratories (ABT) Miles D. White on Q1 2016 Results - Earnings Call Transcript Seeking Alpha, 1 week ago RBC Capital Markets Reaffirms a Outperform Rating on Abbott Laboratories (NYSE:ABT) and $48.00 Target Octafinance, 2 weeks ago
Eurofins Scientific has acquired PerkinElmer, Inc.'s U.S. prenatal screening laboratory services business PerkinElmer Labs/NTD (NTD). Founded more than 30 years ago, NTD is a reference laboratory in the US for first and second trimester prenatal ...American Pharmaceutical Outsourcing, 4 days ago Eurofins Reinforces Its Specialty Clinical Diagnostics Footprint by Acquiring PerkinElmer's NTD Laboratory Services Business Bloomberg, 4 days ago
More from: , Quotenet.com...and 4 other sources
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced that the US Food and Drug Administration (FDA) Office of Orphan Products ...PharmaBiz, 1 week ago FDA Grants Orphan Drug Exclusivity to EVOMELA (melphalan) for Injection, Indicated for Multiple Myeloma Business Wire, 1 week ago Spectrum Pharma Release: FDA Grants Orphan Drug Exclusivity To EVOMELA (melphalan) For Injection, Indicated For Multiple Myeloma BioSpace, 1 week ago SPECTRUM PHARMACEUTICALS : FDA Grants Orphan Drug Exclusivity to EVOMELA (melphalan) for Injection, Indicated for Multiple Myeloma 4 Traders, 1 week ago
Ionis Pharmaceuticals Reports Data Update from Nusinersen Phase 2 Study in Infants with Spinal Muscular Atrophy..
/PRNewswire/ --Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today provided an update on its ongoing open-label Phase 2 clinical study of nusinersen in infants with spinal muscular atrophy (SMA) at the American Academy of Neurology (AAN) meeting in ...ADVFN India, 1 week ago Ionis Pharma Reports Data Update From Nusinersen Phase 2 Study In Infants With Spinal Muscular Atrophy And Reviews Neurological Disease Franchise BioSpace, 1 week ago IONIS PHARMACEUTICALS : Reports Data Update from Nusinersen Phase 2 Study in Infants with Spinal Muscular Atrophy and Reviews Neurological Disease Franchise 4 Traders, 1 week ago
on your WebpageAdd Widget >Get your members hooked!